Basics Allakos Inc. IPO Date: July 16, 2018 Sector: Healthcare Industry: Biotech Market Cap: $29.79M Activated in VL: True Average Daily Range Avg Daily Range: $1.15 | 3.36% Avg Daily Range (30 D): $0.00 | 1.04% Avg Daily Range (90 D): $0.03 | 4.68% Institutional Daily Volume Avg Daily Volume: .77M Avg Daily Volume (30 D): .81M Avg Daily Volume (90 D): 1.93M Trade Size Avg Trade Size (Sh.): 134 Avg Trade Size (Sh.) (30 D): 889 Avg Trade Size (Sh.) (90 D): 666 Institutional Trades Total Inst.Trades: 1,878 Avg Inst. Trade: $2.27M Avg Inst. Trade (30 D): $.94M Avg Inst. Trade (90 D): $.72M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.73M Avg Closing Trade (30 D): $6.43M Avg Closing Trade (90 D): $6.43M Avg Closing Volume: 102.29K         News Apr 2, 2025 @ 12:00 PM Allakos Inc. Enters into Agreement to Be Acquired ... Source: N/A Feb 10, 2025 @ 10:36 PM Kuehn Law Encourages Investors of Allakos Inc. to ... Source: N/A Jan 31, 2025 @ 7:20 PM Deal Dispatch: Sage And Silvus Are Up For Sale, Mr... Source: Anthony Noto Nov 4, 2024 @ 6:00 PM Urticaria Clinical Trial Pipeline Accelerates: 20+... Source: Delveinsight Aug 7, 2024 @ 8:02 PM Allakos Provides Business Update and Reports Secon... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.79 $-.29 $.01 Diluted EPS $-.79 $-.29 $.01 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -70.85M $ -26.18M $ .38M Operating Income / Loss $ -75.87M $ -26.71M $ -.77M Cost of Revenue $ $ $ Net Cash Flow $ -25.31M $ M $ 7.3M PE Ratio